Opportunity ID: 67993

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-CA-11-002
Funding Opportunity Title: SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization (R44)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.394 — Cancer Detection and Diagnosis Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 03, 2011
Last Updated Date:
Original Closing Date for Applications: Apr 07, 2011
Current Closing Date for Applications: Apr 07, 2011
Archive Date: May 08, 2011
Estimated Total Program Funding: $10,000,000
Award Ceiling: $1,000,000
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility:

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for projects that were previously funded by NIH SBIR Phase II awards. Projects proposed in response to this FOA must be applicable to one of the following areas: (1) cancer therapeutics; (2) cancer imaging technologies, interventional devices and in vivo diagnostics; or (3) in vitro and ex vivo cancer diagnostics and prognostics. The purpose of this FOA is to facilitate the transition of SBIR Phase II projects to the commercialization stage. This FOA is expected to promote partnerships between NIHs SBIR Phase II awardees and third-party investors and/or strategic partners to facilitate and accelerate the capital-intensive steps that are required to commercialize new products and technologies. Consistent with the goals of this funding initiative and as required by the SF424 instructions for all Phase II SBIR applications, applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the Bridge Award project period. It is expected that the level of this independent third-party funding will equal or exceed the NCI funds being requested throughout the Phase IIB Bridge Award project period. Proposed projects may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate but are not required..
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-11-002.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
ADOBE-FORMS-B1 ADOBE-FORMS-B1 PKG00030530 Mar 07, 2011 Apr 07, 2011 View

Package 1

Mandatory forms

67993 RR_SF424_1_2-1.2.pdf

67993 SBIR_STTR_Information_1_1-1.1.pdf

67993 RR_OtherProjectInfo_1_3-1.3.pdf

67993 RR_KeyPersonExpanded_1_2-1.2.pdf

67993 RR_Budget-1.1.pdf

67993 PerformanceSite_1_4-1.4.pdf

67993 PHS398_ResearchPlan_1_3-1.3.pdf

67993 PHS398_CoverPageSupplement_1_4-1.4.pdf

67993 PHS398_Checklist_1_3-1.3.pdf

Optional forms

67993 RR_SubawardBudget-1.2.pdf

67993 PHS_CoverLetter_1_2-1.2.pdf

2025-07-12T13:37:47-05:00

Share This Post, Choose Your Platform!

About the Author: